Connect with us
Merck Awarded Australian CRISPR Nickase Patent for Foundational Genome-Editing Technology Merck Awarded Australian CRISPR Nickase Patent for Foundational Genome-Editing Technology

Pharmaceuticals

Fabrication and testing capabilities
Intermolecular stockholders approve acquisition by Merck

Merck, a science and technology company, announced that its proposed transaction with Intermolecular, was approved by the stockholders of Intermolecular...